Food and Drugs Act, R.S.C. 1985, c. F-27

Section 21.91

Additions to Schedule G

Cite as Food and Drugs Act, R.S.C. 1985, c. F-27, s. 21.91 · current to July 24, 2025 · Act last amended March 27, 2025

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) For the purpose of preventing injury to health or preventing a person from being deceived or misled, the Minister may, by order, add a description of a therapeutic product or a class of therapeutic products to Schedule G if the Minister believes that the therapeutic product or products represent an emerging or innovative technological, scientific or medical development. (2) Before adding a description of a therapeutic product or a class of therapeutic products to Schedule G, the Minister shall consider the following factors: (a) the degree of uncertainty respecting the risks and benefits associated with the therapeutic product or products and the measures that are available to adequately manage and control those risks; (b) the extent to which the therapeutic product or products are different from therapeutic products for which therapeutic product authorizations have been issued under the regulations; (c) the extent to which existing legal frameworks are adequate to prevent injury to health or to prevent persons from being deceived or misled; and (d) the prescribed factors, if any. (3) The Minister may, by order, delete the description of a therapeutic product or a class of therapeutic products from Schedule G.
Read the Food and Drugs Act on the Justice Laws Website ↗

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.